Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer

BJU International

Volumn 112, Issue 1, 2013, Pages 81-88

  Yuh, Bertram E ^a   Ruel, Nora H ^a   Mejia, Rosa ^a   Novara, Giacomo ^b   Wilson, Timothy G ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

complications; lymph node dissection; prostate cancer; robotic

Indexed keywords

ADULT; AGED; ALLERGIC REACTION; ANASTOMOSIS LEAKAGE; ANEMIA; ARTICLE; BLADDER SPASM; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIZZINESS; EXTENDED PELVIS LYMPHADENECTOMY; FEVER; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; ILEUS; INTERMETHOD COMPARISON; INTESTINE INJURY; KIDNEY FAILURE; LENGTH OF STAY; LIMITED LYMPH NODE DISSECTION; LUNG EMBOLISM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PELVIS ABSCESS; PELVIS LYMPHADENECTOMY; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; ROBOTICS; SCROTAL PAIN; SCROTAL SWELLING; SURGICAL INFECTION; SURGICAL TECHNIQUE; THORAX PAIN; URETER INJURY; URINE RETENTION;

AGED; FOLLOW-UP STUDIES; HUMANS; ITALY; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROBOTICS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84879090654     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11788.x     Document Type: Article

References (31)

1. Kibel AS, Ciezki JP, Klein EA, et al. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 2012; 187: 1259-1265
2. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG,. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001; 91: 66-73
3. Joslyn SA, Konety BR,. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 2006; 68: 121-125
4. Hyndman ME, Mullins JK, Pavlovich CP,. Pelvic node dissection in prostate cancer: extended, limited, or not at all? Curr Opin Urol 2010; 20: 211-217. Review
5. Polcari AJ, Hugen CM, Sivarajan G, et al. Comparison of open and robot-assisted pelvic lymphadenectomy for prostate cancer. J Endourol 2009; 23: 1313-1317
6. Winter A, Vogt C, Weckermann D, Wawroschek F,. [Complications of pelvic lymphadenectomy in clinically localised prostate cancer: different techniques in comparison and dependency on the number of removed lymph nodes. Aktuelle Urol 2011; 42: 179-183
7. Briganti A, Chun FK, Salonia A, et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 2006; 50: 1006-1013
8. Martin RC 2nd, Brennan MF, Jaques DP,. Quality of complication reporting in the surgical literature. Ann Surg 2002; 235: 803-813
9. Yuh BE, Ruel NH, Mejia R, Wilson CM, Wilson TG,. Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer. Eur Urol 2012; 61: 1009-1010
10. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213
11. Allaf ME, Partin AW, Carter HB,. The importance of pelvic lymph node dissection in men with clinically localized prostate cancer. Rev Urol 2006; 8: 112-119
12. Heidenreich A, Ohlmann CH, Polyakov S,. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 2007; 52: 29-37
13. Briganti A, Larcher A, Abdollah F, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 2012; 61: 480-487
14. Abdollah F, Sun M, Thuret R, et al. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer. Int J Urol 2012; 19: 645-651
15. Godoy G, von Bodman C, Chade DC, et al. Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series. J Urol 2012; 187: 2082-2086
16. Novara G, Ficarra V, D'Elia C, Secco S, Cavalleri S, Artibani W,. Prospective evaluation with standardised criteria for postoperative complications after robotic-assisted laparoscopic radical prostatectomy. Eur Urol 2010; 57: 363-370
17. Rabbani F, Yunis LH, Pinochet R, et al. Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy. Eur Urol 2010; 57: 371-386
18. Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R,. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 2006; 97: 1173-1178
19. Masterson TA, Bianco FJ Jr, Vickers AJ, et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 2006; 175: 1320-1324; discussion 1324-5
20. Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 2009; 55: 1251-1265
21. Eden CG, Arora A, Rouse P,. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer. BJU Int 2010; 106: 537-542
22. Lindberg C, Davidsson T, Gudjõnsson S, Hilmarsson R, Liedberg F, Bratt O,. Extended pelvic lymphadenectomy for prostate cancer: will the previously reported benefits be reproduced in hospitals with lower surgical volumes? Scand J Urol Nephrol 2009; 43: 437-441
23. Arenas LF, Füllhase C, Boemans P, Fichtner J,. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy. Aktuelle Urol 2010; 41 (Suppl. 1): S10-14
24. Khoder WY, Trottmann M, Buchner A, et al. Risk factors for pelvic lymphoceles post-radical prostatectomy. Int J Urol 2011; 18: 638-643
25. Orvieto MA, Coelho RF, Chauhan S, Palmer KJ, Rocco B, Patel VR,. Incidence of lymphoceles after robot-assisted pelvic lymph node dissection. BJU Int 2011; 108: 1185-1190
26. Musch M, Klevecka V, Roggenbuck U, Kroepfl D,. Complications of pelvic lymphadenectomy in 1380 patients undergoing radical retropubic prostatectomy between 1993 and. J Urol 2006; 179: 923-928; discussion 928-9
27. Waldert M, Remzi M, Klatte T, Klingler HC,. FloSeal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomy. J Endourol 2011; 25: 969-973
28. Beyer J, Wessela S, Hakenberg OW, et al. Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery. J Thromb Haemost 2009; 7: 597-604
29. Eifler JB, Levinson AW, Hyndman ME, Trock BJ, Pavlovich CP,. Pelvic lymph node dissection is associated with symptomatic venous thromboembolism risk during laparoscopic radical prostatectomy. J Urol 2011; 185: 1661-1665
30. Heinzer H, Hammerer P, Graefen M, Huland H,. Thromboembolic complication rate after radical retropubic prostatectomy. Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas. Eur Urol 1998; 33: 86-90
31. van der Poel HG, Tillier C, de, Blok W, van, Muilekom E,. Extended nodal dissection reduces sexual function recovery after robot-assisted laparoscopic prostatectomy. J Endourol 2012; 26: 1192-1198